David Speakman
Overview
Explore the profile of David Speakman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
196
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li D, Heffernan K, Koch F, Peake D, Pascovici D, David M, et al.
Int J Mol Sci
. 2024 Nov;
25(21).
PMID: 39519111
The development of a sensitive and specific blood test for the early detection of breast cancer is crucial to improve screening and patient outcomes. Existing methods, such as mammography, have...
2.
Mor E, Baker B, Henderson M, Lazarakis S, Mitchell C, Speakman D, et al.
ANZ J Surg
. 2024 Sep;
94(12):2150-2158.
PMID: 39253994
Purpose: Radiation-induced angiosarcoma (RIAS) of the breast is a rare tumour with high rate of local recurrence. The aim of this study is to evaluate the outcome of radical resections....
3.
Mor E, Tejman-Yarden S, Mor-Hadar D, Assaf D, Eifer M, Nagar N, et al.
Ann Surg Oncol
. 2024 Jun;
31(10):7198-7205.
PMID: 38898325
Background: Retroperitoneal sarcomas (RPSs) present a surgical challenge, with complex anatomic relationships to organs and vascular structures. This pilot study investigated the role of three-dimensional (3D) augmented reality (3DAR) compared...
4.
Carr M, Sun J, Kroon H, Miura J, Beasley G, Farrow N, et al.
Ann Surg Oncol
. 2020 Sep;
27(13):5107-5118.
PMID: 32918177
Background: Isolated limb infusion (ILI) is a minimally invasive procedure for delivering high-dose chemotherapy to extremities affected by locally advanced or in-transit melanoma. This study compared the outcomes of melanoma...
5.
Kenyon-Smith T, Kroon H, Miura J, Teras J, Beasley G, Mullen D, et al.
Eur J Surg Oncol
. 2020 Aug;
46(11):2140-2146.
PMID: 32739218
Introduction: Isolated limb infusion (ILI) is a minimally-invasive procedure for delivering high-dose regional chemotherapy to treat melanoma in-transit metastases confined to a limb. The aim of this international multi-centre study...
6.
Teras J, Kroon H, Miura J, Kenyon-Smith T, Beasley G, Mullen D, et al.
Ann Surg Oncol
. 2020 Mar;
27(5):1420-1429.
PMID: 32152775
Background: Isolated limb infusion (ILI) is used to treat in-transit melanoma metastases confined to an extremity. However, little is known about its safety and efficacy in octogenarians and nonagenarians (ON)....
7.
Tie E, Na L, Hicks R, Spillane J, Speakman D, Henderson M, et al.
Ann Surg Oncol
. 2019 Oct;
26(13):4673-4680.
PMID: 31641949
Background: Patients with in-transit melanoma metastases (ITM) experience a diverse spectrum of clinical presentations and a highly variable disease course. There is no standardized treatment protocol for these patients due...
8.
Banting S, Milne D, Thorpe T, Na L, Spillane J, Speakman D, et al.
Ann Surg Oncol
. 2019 Apr;
26(7):2263-2267.
PMID: 31011899
Background: The majority of patients undergoing sentinel lymph node biopsy (SLNB) for melanoma will have a negative SLN. The long-term sequelae of a negative result are important when discussing this...
9.
Miura J, Kroon H, Beasley G, Mullen D, Farrow N, Mosca P, et al.
Ann Surg Oncol
. 2019 Mar;
26(8):2486-2494.
PMID: 30911949
Background: Isolated limb infusion (ILI) is a minimally invasive procedure for delivering high-dose regional chemotherapy to patients with locally advanced or in-transit melanoma located on a limb. The current international...
10.
Snow H, Riedel B, Gyorki D, Henderson M, Speakman D
ANZ J Surg
. 2018 Mar;
88(3):131-132.
PMID: 29512340
No abstract available.